Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > New Press Release - Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Mar 28, 2024 5:00pm

151 Views

Post# 35959099

RE:RE:RE:New Press Release - Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update

I still cannot get over the fact that they agreed to accept a meager 2 million cad dollrs to grant exclusive marketing rights to Baxter ,,,,,especially considering that ,,,,,results were exceeding expectations and that they dont have enough cash to last more than ???